In Opioid dependence Opioids are prescribed to treat pain. With prolonged use, the body may become dependent on them and cause withdrawal symptoms, which makes it difficult to stop taking them. Naltrawave Tablet helps prevent these cravings that lead to opioid dependence and also helps the person to refrain from taking them repeatedly. In Alcohol addiction Naltrawave Tablet is a medicine used, along with social support and counseling, to help people recover from alcohol addiction and to avoid having the urge to drink alcohol again. Naltrawave Tablet starts working from the very first dose and is a very safe and effective way of treating alcohol addiction.
Consuming alcohol with Naltrawave Tablet does not cause any harmful side effects.
Naltrawave Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Naltrawave Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Naltrawave Tablet may cause side effects which could affect your ability to drive. Naltrawave Tablet may make you feel tired or dizzy. This may affect your driving ability.
Naltrawave Tablet should be used with caution in patients with kidney disease. Dose adjustment of Naltrawave Tablet may be needed. Please consult your doctor.
Naltrawave Tablet should be used with caution in patients with liver disease. Dose adjustment of Naltrawave Tablet may be needed. Please consult your doctor. Regular monitoring of liver function tests is advisable while you are taking this medicine.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Rusan Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ryon Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Consern Pharma Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: DD Pharmaceuticals Pvt. Ltd. || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Synmedic Laboratories || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Psychocare Health Pvt Ltd || ₹14.5/tablet (25% cheaper)